Babatunde D. Babalola
FDA investigator
Appears on 2 documents from 2006 to 2015, mostly at sites in North Carolina. Most often cites production and process controls (21 CFR 820.70).
- 2
- Documents on file
- 10.0
- Observations per 483
- 2006
- First seen
- 2015
- Most recent
What they cite most
From 18 observations- 21 CFR 820.70Production and process controls4
- 21 CFR 820.30Design controls3
- 21 CFR 820.198Complaint files2
- 21 CFR 2111
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.166Stability testing1
Activity by year
2006: 1, 2015: 1
Where
North Carolina 1 · South Carolina 1
Often inspects with
Is Babatunde D. Babalola coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2015-09-24 | 483 Hospira, A Pfizer CompanySep 24, 2015 · Rocky Mount, North Carolina | Rocky Mount, North Carolina | 2 | |
| 2006-05-15 | 483 Bausch & Lomb Inc.May 15, 2006 · Greenville, South Carolina | Greenville, South Carolina | 18 |
About this profile
What does Babatunde D. Babalola inspect?
Babatunde D. Babalola appears on 2 documents on file covering 2 sites, mostly in North Carolina.
What do they cite most often?
21 CFR 820.70 (production and process controls), followed by 21 CFR 820.30 and 21 CFR 820.198.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Babatunde D. Babalola is dated Sep 24, 2015.